OMass Therapeutics extends development runway with completion of £41.5m A Series funding

Antony David | Pharma | Biotech | Feb 19th 2020

Research started in Oxford University’s chemistry laboratories has evolved into a biophysical discovery platform that delivers high-resolution data to aid the discovery of therapeutics for patients suffering from immunological and genetic disorders.

OMass has completed an extended series A financing round of £27.5m from existing investors Syncona and Oxford Sciences Innovation (OSI), who contributed £16.6m and £10.4m respectively, and Oxford University, who brought a further £0.5m. Together with £14m raised in 2008, this brings the A series total to £41.5m

read more...
healthtech

Healthtech start-up calls on virtual reality to help patients ‘be their own specialist’

Antony David | Healthcare | Medical | Jan 31st 2020

Much of the NHS’s digital effort focuses on how to improve clinical outcomes and internal processes, and to reduce the burgeoning costs of healthcare within its walls. Oxfordshire start-up Cognitant has looked beyond these parameters, and set its sights on improving the flow of information to patients.

healthtech

Oxford hospital trust digital chief calls for swifter adoption of technology

Karen David | IT | Healthcare | Medical | AI | Dec 2nd 2019

The new chief digital and partnerships officer for Oxford University Hospitals has called on the health service to recognise the benefits of innovation. 

healthtech

Bill & Melinda Gates funding for pharma firm Enesi

Gill Oliver | Pharma | Healthcare | Biotech | Medical | Oct 30th 2019

Milton-Park based pharma company Enesi has won funding from the Bill & Melinda Gates Foundation to evaluate its tech platform to deliver solid dose vaccines.

healthtech

‘That’s the first bit of good news in years,’ says Professor as he welcomes government U-turn on policy allowing graduates to stay longer

Gill Oliver | Healthcare | Biotech | Aerospace | Sep 13th 2019

The government’s recent decision to allow international students to stay in the UK for two years to find a job after graduation is “wonderful”, according to Professor Lionel Tarassenko, head […]

healthtech

Professor Gil McVean takes on full-time CTO role at Genomics

Gill Oliver | Pharma | Healthcare | Biotech | Sep 7th 2019

Data science company Genomics has announced Professor Gil McVean will join on a full-time basis as chief information officer.

healthtech

Nuclear medicine: Concern for patients

Antony David | Pharma | Medical | Aug 23rd 2019

Clinicians, suppliers and The Royal College of Radiologists continue to be concerned about the possible consequences of the UK's departure from the Euratom Treaty. In Oxford University Hospitals NHS Trust, more than 500,000 procedures each year involve ionising radiation. Uncertainty continues around the safeguarding controls and the continuity of supply of radioisotopes caused by the Brexit negotiations and, in particular, the prospect of a no-deal exit at the end of October.

healthtech

Biotech startup is developing drug discovery programmes in kidney disease and cancer

Gill Oliver | Healthcare | Biotech | Medical | Investment | Feb 19th 2020

Using its proprietary tech, a biotech company has discovered antibodies leading to the development of drug discovery programmes in kidney disease and cancer.

healthtech

Network profile: TheHill digital health community

Antony David | Healthcare | Network profile | Aug 23rd 2019

TheHill is a digital health innovation community, a cluster, network and incubator/accelerator programme working in Oxford with NHS Trusts, universities, digital developers, innovators and investors to catalyse commercial and impactful technological solutions in healthcare. 

healthtech

BOOK REVIEW: Invisible Women by Caroline Criado Perez

Karen David | Book review | Aug 23rd 2019

If you’ve ever wondered why the effects of a prescribed drug were stronger than the doctor promised, why you can’t reach the top shelf in a supermarket, or why you […]

Load More...

Events Coming Soon

28 Feb 2020

Income insecurity in the 21st Century A morning of talks exploring the current challenges of income insecurity, with keynote speaker Andy Haldane, Chief Economist at the Bank of England. Topics include pay volatility and income insecurity issues in the UK, their implications for the labour market and the structure of the social security system. Speakers also include Matteo Richiardi, Professor of Economics and Director of EUROMOD, University of Essex, INET Associate and Jane Millar, Professor of Social Policy, University of Bath. 11.15 to 1pm at Oxford Martin School, Oxford OX1 3BD Details

03 Mar 2020

Introducing Janet Ogundele, non-executive director at HR Wallingford, talks about the successes and challenges she has faced as a woman and person of colour. With more than two decades of experience devising HR strategy, managing change and building best practice HR functions, Janet’s expertise centres around delivery of business results through effective, collaborative and commercial HR interventions. 1 to 2pm, HR Wallingford, Howbery Park Conference Centre. Details.

03 Mar 2020

Introducing Janet Ogundele Non-executive director at HR Wallingford, Janet Ogundele talks about the successes and challenges she has faced as a woman and person of colour. With more than two decades of experience devising HR strategy, managing change and building best practice HR functions, Janet’s expertise centres around delivery of business results through effective, collaborative and commercial HR interventions. 1 to 2pm, HR Wallingford, Howbery Park Conference Centre. Details.

 

See All Events

Subscribe to our newsletter